Analystreport

PDS Biotechnology Co. (NASDAQ: PDSB) had its price target raised by analysts at Chardan Capital from $15.00 to $16.00.

PDS Biotechnology Corporation  (PDSB) 
Last pds biotechnology corporation earnings: 11/7 06:00 am Check Earnings Report